Cargando…
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
Sorafenib, a molecular targeted multi-kinase inhibitor, has received considerable interests in recent years due to its significant profiles of efficacy in cancer therapy. However, poor pharmacokinetic properties such as limited water solubility, rapid elimination and metabolism lead to low bioavaila...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Shenyang Pharmaceutical University
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261086/ https://www.ncbi.nlm.nih.gov/pubmed/34276821 http://dx.doi.org/10.1016/j.ajps.2020.07.003 |